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Both bile acid and phenolic steroid sulfotransferase activities in rat liver cytosol have previously been identi- 
fied in fractions corresponding to apparent molecular masses of 60-70 and 30-35 kDa. We purified the latter 
activity corresponding to a monomeric protein. Activity for bile acids and phenolic steroids co-eluted on 
sequential chromatography on Sephadex G-75 sf, Affigel blue, chromatofocusing and hydroxyapatite. The 
protein was homogeneous onSDS-PAGE (32.5 kDa). 
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1. INTRODUCTION 
Sulfation of bile acids has been implicated as a 
possible protective mechanism against hepatotoxic 
monohydroxy bile acids. Bile acid sulfotrans- 
ferase, an enzyme catalyzing the transfer of a 
sulfate group from 3 '-phosphoadenosine 5'-phos- 
phosulfate (PAPS) to bile acids, was originally 
identified in cytosol of rat liver and kidney [1,2] 
and has been partially purified from guinea pig 
liver [3] and human liver [4]. Much confusion has 
existed regarding the Mr of this enzyme although it 
is generally agreed upon that the subunit has an Mr 
of 30000-35 000. We have previously reported that 
only monomeric and dimeric forms of bile acid 
sulfotransferase can be identified in rat liver 
cytosol [5]. Similar results have been reported by 
Barnes and Spenny [6]. However, when the Mr 
separation has been carried out by others as a late 
step in purification, much larger Mr values have 
been found consistent with only a tetrameric form 
in rat liver [1]. 
We have previously identified the Y' fraction in 
rat liver cytosol. Various activities have been iden- 
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tified in this fraction including bile acid binding 
proteins (33 kDa) [7] which we recently identified 
as 3a-hydroxysteroid ehydrogenases [8] and 
sulfotransferase activity for phenolic steroids and 
bile acids [5]. The sulfotransferases were not 
purified to homogeneity and it was uncertain 
whether activity for both bile acids and phenolic 
steroids resides within the same protein. 
2. MATERIALS AND METHODS 
2.1. Preparation o f  Y '  fract ion 
The livers of male Sprague-Dawley rats weighing 
approx. 250 g were perfused in situ with 0.01 M 
sodium phosphate, 0.25 M sucrose buffer, pH 7.4, 
and removed. Homogenates (33070, w/v) were 
prepared in the same buffer and the supernatant 
(cytosol) was harvested after centrifugation at 
100000 x g for 60 rain [7]. Gel filtration was per- 
formed on Sephadex G-75 sf with 80 ml cytosol on 
a 5 × 100 cm column. Fractions corresponding to 
M~ 30000-35000 (Y' fraction) were pooled for 
further purification. 
2.2. Sulfotransferase assay 
Sulfotransferase activity with taurolithocholate, 
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glycolithocholate and estradiol as substrates was 
measured with the butanol extraction method 
described by Barnes et al. [9]. The incubation mix- 
ture (100/A) consisted of 90/~M PAPS (Sigma, St. 
Louis, MO) with 0.2/xCi [35S]PAPS (1.6 Ci/ 
mmol, New England Nuclear, Boston, MA), 
100/~M acceptor substrates, 5 mM MgCI2 and 
0.1 M sodium phosphate, pH 7.0. In some cases, 
the concentration of unlabeled PAPS was lowered 
to raise its specific activity. Incubations were per- 
formed for 30 rain at 37°C and terminated by boil- 
ing. After dilution with 0.4 ml of 1 M NH4OH, 
products were extracted with 1 ml butanol, washed 
with 0.45 ml of 1 M NH4OH containing 0.1 M 
sodium phosphate buffer, pH 7.0, and an aliquot 
of butanol layer was counted for radioactivity. 
Taurolithocholate was used as substrate to identify 
peaks of enzyme activity during purification. 
However, to avoid any concern about the com- 
pleteness of the butanol extraction of taurolitho- 
cholate-sulfate, final enrichments and recoveries 
were determined on pooled aliquots of each step 
using the less polar glycolithocholate as substrate. 
Uppsala, 1 × 45 cm) which had been equilibrated 
with 0.025 M Bistris-HC1, pH 6.2. The column 
was eluted with 500 ml of a 1:10 dilution of 
polybuffer-HC1, pH 4.6. Fractions were collected 
into tubes containing 1 M sodium phosphate buf- 
fer, pH 8, so that the final pH values of the frac- 
tions were near 7. This neutralization was critical 
for stabilizing the sulfotransferase activities. A28o, 
pH and sulfotransferase and 3o:-hydroxysteroid 
dehydrogenase activities were measured in the 
fractions. 
2.6. Hydroxyapatite chromatography 
The pooled fractions from chromatofocusing 
containing sulfotransferases were dialysed against 
0.01 M potassium phosphate, pH 6.7, and applied 
to a hydroxyapatite column (HA-Ultrogel, LKB, 
1 × 10 cm). The column was washed with 50 ml of 
the same buffer and then eluted with 80 ml of 
0.01-0.2 M potassium phosphate, pH 6.7, and 
finally washed with 0.5 M buffer. A28o and 
sulfotransferase activities were measured in the 
fractions. 
2.3. 3o:-Hydroxysteroid dehydrogenase assay 
3oz-Hydroxysteroid dehydrogenase activity was 
measured by monitoring the production of 
NADPH as the increase in A340 at 37°C [10]. The 
incubation mixture (2 ml) consisted of 1.47 mM 
acenaphthenol, 250/~M NADP in 0.05 M glycine- 
NaOH buffer, pH 9.0. 
2.4. Affigel blue chromatography 
Pooled Y' fraction with added EDTA (final 
concentration 2 mM) was applied to an Affigel 
blue column (Biorad, 2.5 x 17 cm) which was 
equilibrated with 0.01 M sodium phosphate, 
2 mM EDTA buffer, pH 7.4. After washing the 
column with 70 ml starting buffer followed by 
200 ml starting buffer containing 0.55 M NaCI, 
the column was eluted with 500 ml of a linear Na 
gradient (0.55 to 2.5 M). A280, sulfotransferase 
and 3o:-hydroxysteroid dehydrogenase activities 
were measured in the fractions. 
2.5. Chromatofocusing 
The pooled fractions of enzyme activity from 
Affigel blue were concentrated by ultrafiltration 
with a PM-10 membrane and applied to a 
chromatofocusing column (PBE94, Pharmacia, 
2.7. SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) 
SDS-PAGE was performed according to Laem- 
mli [11] with 12.5°70 gel, using Mr protein 
standards. 
3. RESULTS 
As we have previously reported [5], in gel filtra- 
tion of rat liver cytosol sulfotransferase activity for 
taurolithocholate and estradiol was identified in 
fractions corresponding to molecular masses of 
60-70 kDa and 30-35 kDa (not shown). The latter 
fractions (Y'), which also contain 3c~- 
hydroxysteroid dehydrogenases, were pooled and 
further purified on Affigel blue (fig.l). 
The bulk of activity of sulfotransferase for 
taurolithocholate and estradiol and 3o:- 
hydroxysteroid dehydrogenase coeluted after the 
salt gradient. No enzyme activity was eluted after 
washing the column with 2.5 M NaC1. The pooled 
fractions were next subjected to chromatofocusing 
which separated the dehydrogenases and 
sulfotransferase (fig.2). Two peaks of 3o:- 
hydroxysteroid dehydrogenase, eluting at pH 5.6 
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Fig.l. Affigel bluc chromatography of Y' fraction. Sulfotransferase activities were measured with 90 #M PAPS. See 
section 2 for details. Horizontal bar indicates fractions pooled for further purification. 
¢N 
-l" 
• • ° ° • ° . . o o . ° _~ -16~/1  I1* 
11 II J4  | 7< 
11 II | -7 
0.2 -  ¢x "~" 
, 
0 0 ~0 ~ 0 
20 40 60 80 100 120 140 160 
FRACTION NUMBER 
Fig.2. Chromatofocusing of pooled sulfotransferase and 3ce-hydroxysteroid dehydrogenase from Affigel blue. 
Sulfotransferase activities werc measured with 90/~M PAPS for estradiol and with 2/zM PAPS for taurolithocholate. 
See section 2 for details. Fractions 148-156 were pooled for further purification. 
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Fig.3. Hydroxyapatite chromatography of pooled 
sulfotransferase from chromatofocusing. Sulfotransfer- 
ase activities were measured with 2,aM PAPS. 
Taurolithocholate sulfotransferase activity (upper panel) 
was only detected in the peak corresponding toestradiol 
sulfotransferase activity. See section 2 for details. 
Fractions 33-40 were pooled for SDS-PAGE. 
and 5.5, correspond to the previously identified 
bile acid binders I and II, respectively [7]. 
Sulfotransferase activity for taurolithocholate and 
estradiol co-eluted at pH 5.1. The sulfotransferase 
was further purified on hydroxyapatite column 
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Fig.4. SDS-PAGE of sulfotransferase from hydroxy- 
apatite. 3.5 ,ag protein was used. Numbers correspond to 
molecular mass standards (kDa). 
(fig.3). Sulfotransferase activity for taurolitho- 
cholate and estradiol co-eluted after initiating the 
salt gradient. The purified protein was homo- 
geneous (Mr 32500) on SDS-PAGE (fig.4). Table 
1 summarizes the purification procedure. Poor 
recovery reflects the marked instability of this en- 
zyme. Although addition of 20% glycerol in each 
step improved stability, the resolution was 
markedly worsened precluding purification to 
homogeneity. 
Table 1 
Purification of sulfotransferase 
Estradiol sulfotransferase Glycolithocholate sulfotransferase 
Protein Spec. act. Total activity Spec. act. Total activity 
(mg)  (pmol/min per (pmol/min) (pmol/min per (pmol/min) 
mg protein) mg protein) 
Sephadex G-75 sf 160 290 46400 9.3 1485 
Affigel blue 28 294 8230 (17.7%) 17.3 483 (32.5%) 
Chromatofocusing 1.3 523 680 (1.5%) 42.5 55.2 (3.7%) 
Hydroxyapatite 0.16 831 133 (0.3%) 93.8 15.0 (1.0%) 
Est[adiol (100 ,aM) or glycolithocholate (100,uM) and [35S]PAPS (90/zM) were incubated with protein for 30 min and 
sulfated product measured according to Barnes et al. [9]. Values in parentheses indicate recoveries 
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4. DISCUSSION 
We previously identified bile acid and phenolic 
steroid sulfotransferase activity in the Y' fraction 
(Mr 30000-35 000) but were unable to determine if
both activities reside within the same protein. We 
now report the first successful purification of this 
protein Io homogeneity. Our approach beginning 
with molecular sieving, rather than ending the 
purification scheme with it, permitted the iden- 
tification of a monomeric form. The enzyme xists 
in rat liver cytosol as a monomeric form 
(32.5 kDa) and exhibits activity with both bile 
acids and phenolic steroids. 
Due to marked instability of the enzyme and 
poor recovery, we cannot exclude the possibility 
that other monomeric forms of sulfotransferase 
exist with distinct specificities for bile acids vs 
steroids. However, we found only one peak of en- 
zyme activity with both substrates at each step in 
purification. Thus, although we could have lost 
other forms, we successfully isolated one form 
with activity for both bile acids and estradiol. 
Since the sulfotransferase activity for both bile 
acids and phenolic steroids also elute in gel filtra- 
tion at Mr 60000-70000, it is likely that dimeric 
form(s) of this enzyme also are present in rat liver 
cytosol. Future work will determine if these 
dimeric forms are homodimers of the monomeric 
form we have purified. 
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